Review of treatment trials in human spinal cord injury: Issues, difficulties, and recommendations

被引:241
作者
Tator, Charles H.
机构
[1] Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada
[2] Univ Toronto, Toronto, ON, Canada
关键词
review; human spinal cord injury; treatment trials;
D O I
10.1227/01.NEU.0000245591.16087.89
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: To provide a comprehensive review of the treatment trials in the field of spinal cord injury, emphasizing what has been learned about the effectiveness of the agents and strategies tested and the quality of the methodology. The review aims to provide Useful information for the improvement of future trials. The review audience includes practitioners, researchers, and consumers. METHODS: All publications describing organized trials since the 1960s were analyzed in detail, emphasizing randomized, prospective controlled trials and published Phase I and II trials. Trials were categorized into neuroprotection, surgery, regeneration, and rehabilitation trials. Special attention was paid-to design, outcome measures, and case selection. RESULTS: There are 10 randomized prospective control trials in the acute phase that have provided much useful information. Current neurological grading systems are greatly improved, but still have significant shortcomings, and independent, trained, and blinded examiners are mandatory. Other trial designs should be considered, especially those using adaptive randomization. Only methylprednisolone and thyrotropin-releasing hormone have been shown to,be effective, but the results of the former are controversial, and studies involving the latter involved too few patients. None of the surgical trials has proven effectiveness. Currently, a multitude of cell-based Phase I trials in several countries are attracting large numbers of patients, but such treatments are unproven in effectiveness and may cause harm. Only a small number are being conducted in a randomized or blinded format. Several consortia have committed to a promise to improve the conduct of trials. CONCLUSION: A large number of trials in the field of spinal cord injury have been conducted, but with few proven gains for patients. This review reveals several shortcomings in trial design and makes several recommendations for improvement.
引用
收藏
页码:957 / 982
页数:26
相关论文
共 177 条
[1]  
Amador Maria J, 2005, J Neurol Phys Ther, V29, P70
[2]   Recommended guidelines for studies of human subjects with spinal cord injury [J].
Anderson, DK ;
Beattie, M ;
Blesch, A ;
Bresnahan, J ;
Bunge, M ;
Dietrich, D ;
Dietz, V ;
Dobkin, B ;
Fawcett, J ;
Fehlings, M ;
Fischer, I ;
Grossman, R ;
Guest, J ;
Hagg, T ;
Hall, ED ;
Houle, J ;
Kleitman, N ;
McDonald, J ;
Murray, M ;
Privat, A ;
Reier, P ;
Steeves, J ;
Steward, O ;
Tetzlaff, W ;
Tuszynski, MH ;
Waxman, SG ;
Whittemore, S ;
Wolpaw, J ;
Young, W ;
Zheng, B .
SPINAL CORD, 2005, 43 (08) :453-458
[3]   Targeting recovery: Priorities of the spinal cord-injured population [J].
Anderson, KD .
JOURNAL OF NEUROTRAUMA, 2004, 21 (10) :1371-1383
[4]  
[Anonymous], COCHRANE DATABASE SY, DOI [DOI 10.1002/14651858.CD001046, 10.1002/14651858.CD001046]
[5]   Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays [J].
Bareyre, FM ;
Schwab, ME .
TRENDS IN NEUROSCIENCES, 2003, 26 (10) :555-563
[6]  
BARROS TE, 2003, J SPINAL CORD MED, V26, pS33
[7]   RECOVERY OF SPINAL-CORD FUNCTION [J].
BEDBROOK, G .
PARAPLEGIA, 1980, 18 (05) :315-323
[8]   Bayesian clinical trials [J].
Berry, DA .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (01) :27-36
[9]   Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis [J].
Berry, DA .
CLINICAL TRIALS, 2005, 2 (04) :295-300
[10]   Clinical trials - Is the Bayesian approach ready for prime time? Yes! [J].
Berry, DA .
STROKE, 2005, 36 (07) :1621-1622